FIELD: organic chemistry, medicine, pharmacy.
SUBSTANCE: invention describes derivatives of 4-phenylpyridine N-oxides of the general formula (I) and their pharmaceutically acceptable acid-additive salts wherein R means hydrogen atom, lower alkyl or halogen atom; R1 means hydrogen atom; R2 and R2' mean independently of one another hydrogen, halogen atom, trifluoromethyl group, (lower)-alkoxy-group; or R2 and R2' can mean in common the group -CH=CH-CH=CH- optionally substituted with one or two substitutes taken among lower alkyl or (lower)-alkoxy-group; R3 and R3' mean independently of one another hydrogen atom, lower alkyl; R4 and R4' mean independently of one another -(CH2)mOR6 or lower alkyl; or R4 and R4' form in common with N-atom to which they are bound substituted R5-cyclic tertiary amine representing pyrrolidine-1-yl, piperidine-1-yl, piperazine-1-yl, morpholine-4-yl or 1,1-dioxomorpholine-4-yl; R5 means hydrogen atom, hydroxyl, -COOR3, -N(R3)CO-lower alkyl or -C(O)R3; R6 means hydrogen atom, lower alkyl; X means -C(O)N(R6)-, -N(R6)C(O)-; n = 0, 1, 2, 3 or 4; m = 1, 2 or 3. Also, invention describes a medicinal agent comprising these compounds. Compounds can be used as drugs in treatment or prophylaxis of diseases associated with antagonists of NK-1 receptor.
EFFECT: valuable medicinal properties of agent.
6 cl, 32 ex
Title | Year | Author | Number |
---|---|---|---|
APPLICATION OF RECEPTOR NK-1 ANTAGONISTS FOR TREATING CRANIOCEREBRAL AND SPINAL TRAUMAS OR NERVOUS TISSUE LESION | 2002 |
|
RU2304435C2 |
DERIVATIVES OF 4-PHENYLPYRIDINE AND MEDICINAL AGENT BASED ON THEREOF | 2001 |
|
RU2277087C2 |
DERIVATIVES OF 4-PHENYLPYRIDINE AND MEDICINAL AGENT | 2001 |
|
RU2276139C2 |
DERIVATIVES OF BENZENE OR PYRIDINE AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 2000 |
|
RU2238264C2 |
DERIVATIVES OF 3-PHENYLPYRIDINE AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 2000 |
|
RU2236402C2 |
DERIVATIVES OF 4-PHENYLPYRIMIDINE AND PHARMACEUTICAL COMPOSITION | 2000 |
|
RU2243221C2 |
TRI-SUBSTITUTED AMINE COMPOUNDS AND THEIR APPLICATION AS INHIBITORS OF CHOLESTEROL ESTER TRANSFER PROTEIN (CETP) | 2007 |
|
RU2412937C2 |
DERIVATIVES OF 5-PHENYLPYRIMIDINE AND PHARMACEUTICAL COMPOSITION | 2000 |
|
RU2244710C2 |
DERIVATIVES OF DIHYDROBENZO[b][1,4]DIAZEPINE-2-ONE AS ANTAGONISTS OF MGLUR2 II | 2002 |
|
RU2263112C2 |
AMINOSUBSTITUTED PYRAZOLES AND INTERMEDIATE AMINO SUBSTITUTED PYRAZINES | 1993 |
|
RU2142455C1 |
Authors
Dates
2005-12-20—Published
2001-07-09—Filed